StockData
Nephros Inc logo

Nephros Inc (NEPH) stock

NEPHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3020% below fair value
$2.90−0.10 (-3.33%)

Close on Nov 17, 2026Market cap $31.49MP/E 18.1Yield –

Nephros pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Nephros's pe ratio was 19.2× on Nov 11, 2026, against 37.5× a year earlier. Over the last 3 years it ranged from 0.2× to 200.0×, with a median of 26.8×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202619.2×−18.3
2025Dec 31, 202537.5×+28.1
2014Apr 30, 20149.4×+6.9
2012Jan 31, 20122.6×+0.6
2011Dec 30, 20112.0×–

More Nephros figures

See a number that looks wrong?